Antibiotic | Gender (n, %) | P | Age (n, %) | P | Endoscopic findings (n, %) | P | ||||
---|---|---|---|---|---|---|---|---|---|---|
Male (n = 74) | Female (n = 79) | 18–40 (n = 17) | 41–55 (n = 108) |  ≥ 56 (n = 28) | NPU (n = 108) | PU (n = 45) | ||||
Clarithromycin | 17 (22.9) | 25 (31.6) | 0.193 | 3 (17.6) | 29 (27.4) | 10 (35.7) | 0.415 | 33 (31.1) | 9 (20.0) | 0.163 |
Levofloxacin | 16 (21.6) | 32 (40.5) | 0.012 * | 7 (41.1) | 34 (31.5) | 7 (25.0) | 0.525 | 37 (34.3) | 11 (24.4) | 0.233 |
Metronidazole | 62 (83.7) | 70 (88.6) | 0.386 | 14 (82.3) | 92 (85.2) | 26 (92.8) | 0.508 | 95 (88.0) | 37 (82.2) | 0.347 |
Amoxicillin | 7 (9.5) | 17 (21.5) | 0.040* | 2 (11.7) | 17 (15.7) | 5 (17.8) | 0.862 | 15 (13.9) | 9 (20.0) | 0.344 |
Rifampicin | 54 (72.9) | 58 (73.4) | 0.951 | 12 (70.5) | 78 (72.2) | 22 (78.5) | 0.770 | 76 (70.4) | 36 (80.0) | 0.220 |